178 related articles for article (PubMed ID: 8332282)
21. [Preliminary study on bone loss rate in early and late stages of post-menopausal women].
Xu H; Wu Y; Yan Y
Zhonghua Fu Chan Ke Za Zhi; 1998 Sep; 33(9):542-5. PubMed ID: 10806731
[TBL] [Abstract][Full Text] [Related]
22. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
[TBL] [Abstract][Full Text] [Related]
23. Basal plasma levels of calcitonin and bone mineral mass in normal and uremic women. Effect of menopause.
Corghi E; Ortolani S; Bianchi ML; Favini P; Vigo P; Polli EE
Biomed Pharmacother; 1984; 38(5):263-5. PubMed ID: 6525424
[TBL] [Abstract][Full Text] [Related]
24. Calcitonin reserve and the differentiated response to calcitonin in osteoporosis.
Vlăduţiu T; Lopez A; Gozariu L; Barabaş E
Endocrinologie; 1990; 28(3-4):139-47. PubMed ID: 2103972
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of the use of calcitonin in rheumatoid arthritis by bone densitometry and the study of of phospho-calcium metabolism].
Pappalardo A; Rizzo AG; Buccheri C; Letizia G; Mattina A; Mazzola FG
Clin Ter; 1994 Feb; 144(2):99-105. PubMed ID: 8181213
[TBL] [Abstract][Full Text] [Related]
26. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
[TBL] [Abstract][Full Text] [Related]
27. Determinants of bone mass in postmenopausal women.
Aloia JF; Vaswani AN; Yeh JK; Ross P; Ellis K; Cohn SH
Arch Intern Med; 1983 Sep; 143(9):1700-4. PubMed ID: 6615091
[TBL] [Abstract][Full Text] [Related]
28. Modifications of the bone turnover in operated patients of bilateral ovariectomy.
Lo Dico G; Milazzo I; Alongi G; Savatteri L
Panminerva Med; 1990; 32(4):176-80. PubMed ID: 2090991
[TBL] [Abstract][Full Text] [Related]
29. Calcitonin secretion in postmenopausal osteoporosis.
Tiegs RD; Body JJ; Wahner HW; Barta J; Riggs BL; Heath H
N Engl J Med; 1985 Apr; 312(17):1097-100. PubMed ID: 3982469
[TBL] [Abstract][Full Text] [Related]
30. Effects of salmon calcitonin on the bone loss induced by ovariectomy.
Mazzuoli GF; Tabolli S; Bigi F; Valtorta C; Minisola S; Diacinti D; Scarnecchia L; Bianchi G; Piolini M; Dell'Acqua S
Calcif Tissue Int; 1990 Oct; 47(4):209-14. PubMed ID: 2242492
[TBL] [Abstract][Full Text] [Related]
31. Influence of heavy smoking upon the bone mineral content of the radius of the aged and effect of tobacco smoke on the sensitivity to calcitonin of rats.
Holló I; Gergely I; Boross M
Aktuelle Gerontol; 1979 Aug; 9(8):365-8. PubMed ID: 39459
[TBL] [Abstract][Full Text] [Related]
32. Preventive effect of estrogen on postmenopausal bone loss.
Meema S; Bunker ML; Meema HE
Arch Intern Med; 1975 Nov; 135(11):1436-40. PubMed ID: 1190928
[TBL] [Abstract][Full Text] [Related]
33. The effect of intranasal salmon calcitonin on biochemical parameters of bone turnover in postmenopausal women.
Balint-Perić LA; Prelević GM; Beslagić Z; Petrović J
Gynecol Endocrinol; 1994 Dec; 8(4):241-5. PubMed ID: 7709763
[TBL] [Abstract][Full Text] [Related]
34. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.
Overgaard K; Hansen MA; Nielsen VA; Riis BJ; Christiansen C
Am J Med; 1990 Jul; 89(1):1-6. PubMed ID: 2152594
[TBL] [Abstract][Full Text] [Related]
35. Radial bone mineral content in healthy Mexican women.
Forsbach G; Santos A; de los Santos F; Quiroga R
Arch Invest Med (Mex); 1989; 20(2):157-61. PubMed ID: 2604500
[TBL] [Abstract][Full Text] [Related]
36. [The effect of hyperprolactinemia on biohumoral parameters of bone metabolism in women of reproductive age on chronic hemodialysis].
Petrović MS; Prelević GM; Balint-Perić LjA; Radmilović AV
Srp Arh Celok Lek; 1992; 120(1-2):15-8. PubMed ID: 1641694
[TBL] [Abstract][Full Text] [Related]
37. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
Tolino A; Romano L; Ronsini S; Riccio S; Montemagno U
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):358-60. PubMed ID: 8370634
[TBL] [Abstract][Full Text] [Related]
38. [Nutrients, anthropometric characteristics and osteoporosis in women in the recent and late postmenopausal period].
Rubinacci A; Porrini M; Sirtori P; Galli L; Tessari L
Minerva Med; 1992 Sep; 83(9):497-506. PubMed ID: 1436598
[TBL] [Abstract][Full Text] [Related]
39. Changes in mineral content and biochemical bone markers at the menopause.
Mazzuoli G; Minisola S; Valtorta C; Antonelli R; Tabolli S; Bigi F
Isr J Med Sci; 1985 Nov; 21(11):875-7. PubMed ID: 4077482
[TBL] [Abstract][Full Text] [Related]
40. Nasal calcitonin for treatment of established osteoporosis.
Overgaard K; Riis BJ; Christiansen C; Pødenphant J; Johansen JS
Clin Endocrinol (Oxf); 1989 Apr; 30(4):435-42. PubMed ID: 2688995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
